Literature DB >> 26614347

In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.

Maria Pennuto1, Manuela Basso2.   

Abstract

Spinal and bulbar muscular atrophy (SBMA) is an X-linked neuromuscular disease characterized by late-onset, progressive degeneration of lower motor neurons and skeletal muscle atrophy. SBMA is caused by expansions of a CAG trinucleotide repeat in the gene encoding the androgen receptor (AR). One striking feature of SBMA is sex specificity: SBMA fully manifests only in males, whereas females show subclinical or mild disease manifestations even when homozygous for the mutation. Since the identification of the mutation responsible for SBMA in 1991, several cell and animal models have been developed to recapitulate the main features of disease in vitro and in vivo. In this review, we describe the most widely used cellular and animal models of SBMA, highlighting advantages and disadvantages in the use of these models to gain mechanistic and therapeutic insights into SBMA.

Entities:  

Keywords:  Androgen receptor; Cell models; Knock-in mice; Mouse models; Muscle cells; Neuronal cells; Spinal and bulbar muscular atrophy; Transgenic mice

Mesh:

Substances:

Year:  2015        PMID: 26614347     DOI: 10.1007/s12031-015-0677-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  42 in total

1.  Distinct Etiological Roles for Myocytes and Motor Neurons in a Mouse Model of Kennedy's Disease/Spinobulbar Muscular Atrophy.

Authors:  Firyal Ramzan; Mike McPhail; Pengcheng Rao; Kaiguo Mo; Katherine Halievski; Ashlyn Swift-Gallant; Lucia Mendoza-Viveros; Hai-Ying M Cheng; D Ashley Monks
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

2.  Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.

Authors:  Christopher Grunseich; Kristen Zukosky; Ilona R Kats; Laboni Ghosh; George G Harmison; Laura C Bott; Carlo Rinaldi; Ke-lian Chen; Guibin Chen; Manfred Boehm; Kenneth H Fischbeck
Journal:  Neurobiol Dis       Date:  2014-06-09       Impact factor: 5.996

Review 3.  Neurotoxic effects of androgens in spinal and bulbar muscular atrophy.

Authors:  Sara Parodi; Maria Pennuto
Journal:  Front Neuroendocrinol       Date:  2011-07-01       Impact factor: 8.606

4.  Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development.

Authors:  Ryan L Sheppard; Espen E Spangenburg; Eva R Chin; Stephen M Roth
Journal:  Physiol Genomics       Date:  2011-08-09       Impact factor: 3.107

5.  Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Satya L Reddy; Diane E Merry; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Diane M Robins; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2013-10-22       Impact factor: 6.150

6.  Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model.

Authors:  Zhigang Yu; Nahid Dadgar; Megan Albertelli; Kirsten Gruis; Cynthia Jordan; Diane M Robins; Andrew P Lieberman
Journal:  J Clin Invest       Date:  2006-09-14       Impact factor: 14.808

7.  B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy.

Authors:  Isabella Palazzolo; Natalia B Nedelsky; Caitlin E Askew; George G Harmison; Aleksey G Kasantsev; J Paul Taylor; Kenneth H Fischbeck; Maria Pennuto
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

8.  Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

Authors:  Ken-ichi Takeyama; Saya Ito; Ayako Yamamoto; Hiromu Tanimoto; Takashi Furutani; Hirotaka Kanuka; Masayuki Miura; Tetsuya Tabata; Shigeaki Kato
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

9.  Evaluation of the spinal cord neuron X neuroblastoma hybrid cell line NSC-34 as a model for neurotoxicity testing.

Authors:  H D Durham; S Dahrouge; N R Cashman
Journal:  Neurotoxicology       Date:  1993       Impact factor: 4.294

Review 10.  Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases.

Authors:  Fabio Sambataro; Maria Pennuto
Journal:  Prog Neurobiol       Date:  2011-11-02       Impact factor: 11.685

View more
  11 in total

1.  Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.

Authors:  Maria Pennuto; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02-13       Impact factor: 3.444

Review 2.  Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy.

Authors:  Neha Gogia; Luhan Ni; Victor Olmos; Fatema Haidery; Kimberly Luttik; Janghoo Lim
Journal:  Front Mol Neurosci       Date:  2022-06-03       Impact factor: 6.261

3.  ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease.

Authors:  Vladimir A Martínez-Rojas; Aura M Jiménez-Garduño; Daniela Michelatti; Laura Tosatto; Marta Marchioretto; Daniele Arosio; Manuela Basso; Maria Pennuto; Carlo Musio
Journal:  J Mol Neurosci       Date:  2020-08-28       Impact factor: 3.444

4.  Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy.

Authors:  Vladimir A Martínez-Rojas; Daniele Arosio; Maria Pennuto; Carlo Musio
Journal:  Pflugers Arch       Date:  2021-05-22       Impact factor: 3.657

5.  Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.

Authors:  Anna Rocchi; Carmelo Milioto; Sara Parodi; Andrea Armirotti; Doriana Borgia; Matteo Pellegrini; Anna Urciuolo; Sibilla Molon; Valeria Morbidoni; Manuela Marabita; Vanina Romanello; Pamela Gatto; Bert Blaauw; Paolo Bonaldo; Fabio Sambataro; Diane M Robins; Andrew P Lieberman; Gianni Sorarù; Lodovica Vergani; Marco Sandri; Maria Pennuto
Journal:  Acta Neuropathol       Date:  2016-03-12       Impact factor: 17.088

6.  Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes.

Authors:  Carmelo Milioto; Adriana Malena; Eleonora Maino; Maria J Polanco; Caterina Marchioretti; Doriana Borgia; Marcelo Gomes Pereira; Bert Blaauw; Andrew P Lieberman; Roberta Venturini; Mario Plebani; Fabio Sambataro; Lodovica Vergani; Elena Pegoraro; Gianni Sorarù; Maria Pennuto
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

7.  Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients.

Authors:  Doriana Borgia; Adriana Malena; Marco Spinazzi; Maria Andrea Desbats; Leonardo Salviati; Aaron P Russell; Giovanni Miotto; Laura Tosatto; Elena Pegoraro; Gianni Sorarù; Maria Pennuto; Lodovica Vergani
Journal:  Hum Mol Genet       Date:  2017-03-15       Impact factor: 6.150

8.  DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5.

Authors:  Naohide Kondo; Genki Tohnai; Kentaro Sahashi; Madoka Iida; Mayumi Kataoka; Hideaki Nakatsuji; Yutaka Tsutsumi; Atsushi Hashizume; Hiroaki Adachi; Haruki Koike; Keiko Shinjo; Yutaka Kondo; Gen Sobue; Masahisa Katsuno
Journal:  EMBO Mol Med       Date:  2019-05       Impact factor: 12.137

9.  Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism.

Authors:  Mathilde Chivet; Caterina Marchioretti; Marco Pirazzini; Diana Piol; Chiara Scaramuzzino; Maria Josè Polanco; Vanina Romanello; Emanuela Zuccaro; Sara Parodi; Maurizio D'Antonio; Carlo Rinaldi; Fabio Sambataro; Elena Pegoraro; Gianni Soraru; Udai Bhan Pandey; Marco Sandri; Manuela Basso; Maria Pennuto
Journal:  Cells       Date:  2020-01-30       Impact factor: 6.600

Review 10.  Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.

Authors:  Frederick J Arnold; Diane E Merry
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.